Showing results (71-80 of 177) with videos related to

Sort By:
Pageof 18
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 24, 2010
[Successful long-term management of hepatic and lymph nodes metastases of ureteral cancer by multimodal treatment including radiofrequency ablation]Yosuke Yasuda, Manabu Tatokoro, Minato Yokoyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 6, 2009
Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility studyMinato Yokoyama, Yasuhisa Fujii, Soichiro Yoshida, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 4, 2011
[Successful treatment with multidisciplinary therapy including low-dose chemoradiotherapy against metastatic recurrences of small cell carcinoma of the renal pelvis: a case report]Hiroshi Fukushima, Fumitaka Koga, Manabu Tatokoro, et al.
BJU International|May 12, 2006
Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tractYukihiro Ohtsuka, Satoru Kawakami, Yasuhisa Fujii, et al.
Urology|May 6, 2008
Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysisFumitaka Koga, Soichiro Yoshida, Satoru Kawakami, et al.
Cancer Science|October 27, 2010
Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinomaManabu Tatokoro, Yasuhisa Fujii, Satoru Kawakami, et al.
Japanese Journal of Clinical Oncology|October 14, 2011
Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomyAki Iwai, Fumitaka Koga, Yasuhisa Fujii, et al.
BJU International|January 15, 2008
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapySoichiro Yoshida, Kazutaka Saito, Fumitaka Koga, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 6, 2009
Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomyNoboru Numao, Satoru Kawakami, Junji Yonese, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
The Controlling Nutritional Status (CONUT) Score is a Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with First-Line Platinum-Based ChemotherapyHiroaki Suzuki, Masaya Ito, Kosuke Takemura, et al.
Pageof 18